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This paper describes preparation and characterization of beads of alginate and psyllium containing probiotic bacteria of
Lactobacillus acidophilus DMSZ20079. Twelve diﬀerent formulations containing alginate (ALG) and alginate-psyllium (ALG-
PSL) were prepared using extrusion technique. The prepared beads were characterized in terms of size, morphology and surface
properties, encapsulation eﬃciency, viabilities in acid (pH 1.8, 2 hours) and bile (0.5% w/v, 2 hours) conditions, and release in
simulated colon pH conditions. The results showed that spherical beads with narrow size distribution ranging from 1.59 ±0.04 to
1.67±0.09mm for ALG and from 1.61±0.06 to 1.80±0.07 mm for ALG-PSL with encapsulation eﬃciency higher than 98% were
achieved. Furthermore,addition of PSL into ALGenhanced theintegrityof prepared beads in comparison with ALGformulations.
The results indicated that incorporation of PSL into alginate beads improved viability of the bacteria in acidic conditions as well
as bile conditions. Also, stimulating eﬀect of PSL on the probiotic bacteria was observed through 20-hour incubation in simulated
colonic pH solution. According to our in vitro studies, PSL can be a suitable polymer candidate for partial substitution with ALG
for probiotic coating.
1.Introduction
“Probiotics are live microorganisms (bacteria or yeasts),
which when ingested or locally applied in suﬃcient numbers
confer one or more speciﬁed demonstrated health beneﬁts
for the host” [1]. These beneﬁts include maintenance of
normalintestinalmicroﬂora,defenseagainstenteropathogen
infections, controlling serum cholesterol levels, improving
lactose utilization in persons who are lactose maldigesters by
production of β-galactosidase, and possessing anticarcino-
genic and antimutagenic activities [2–4].
Probiotics can be bacteria, moulds, and yeasts. How-
ever, most of probiotics are bacteria; among them lactic
acid bacteria (LAB), typically associated with the human
gastrointestinal tract, are the most widely used probiotic
microorganisms. In order to exhibit their potential beneﬁts,
probiotics need to pass the harsh conditions of gastric
tract and colonize and grow on the epithelium of colon in
appropriate population [5]. It is suggested that probiotics
should be formulated in products in a minimum count
of 106-7 CFU/g or mL of viable probiotic bacteria [1]. To
improve viability and stability of probiotics and eﬃcient
delivery of the cells to their active sites, various techniques
have been utilized so far. In this regard, encapsulation of
probiotics in wide variety of polymers is the most frequently
applied method that is cited in numerous studies [6].
Alginate, a commonly used material to encapsulate
probiotics, is a naturally occurring biocompatible and
biodegradable linear anionic polysaccharide. Preparation of
alginate bead, with well retained bacteria in their matrix,
can be easily achieved by simple techniques like extrusion
or emulsion methods. In spite of the wide application of
alginate microcapsules in this area, some problems related to
protection eﬃciency of them have been reported including2 The Scientiﬁc World Journal
susceptibility to disintegration in the presence of excess
monovalent ions, Ca2+ chelating agents, and harsh chemical
environments [4].
Psyllium,thecommonnameusedforseveralmembersof
the plant genus Plantago, is gel-forming mucilage composed
of a highly branched arabinoxylan. The backbone consists
of xylose units, while arabinose and xylose form the side
chains [7, 8]. Psyllium has been reported as a medicinally
active natural polysaccharide for the treatment of consti-
pation, diarrhea, irritable bowel syndrome, inﬂammatory
bowel disease ulcerative colitis, colon cancer, diabetes, and
hypercholesterolemia [9]. Moreover, psyllium as a soluble
ﬁber has a potential to stimulate bacterial growth in digestive
system, and, in some reports, it has been used as prebiotic
[10–13]. Prebiotics is deﬁned by Gibson and Roberfroid [14]
as “non-digestible food ingredients that beneﬁcially aﬀects
the host by selectively stimulating the growth and/or activity
of one or a limited number of bacteria in the colon, and thus
improves host health.”
Having in mind the pharmacological beneﬁts of psyllium
in digestive system as well as its potential to stimulate
probiotic growth in the colon, here we aimed to incorporate
psyllium in alginate beads containing probiotic bacteria L.
acidophilus DMSZ20079.
To this end, diﬀerent formulations containing ALG
and/or ALG-PSL were prepared using extrusion technique
and characterized in terms of size, morphology and surface
properties, encapsulation eﬃciency (EE), viabilities in acid
(pH 1.8, 2 hours) and bile (0.5% w/v, 2 hours) conditions,
and release in simulated colon pH conditions.
2.MaterialsandMethods
2.1. Materials. L. acidophilus DSMZ20079 was obtained
from DSMZ (Germany), pepsin, pancreatin, sodium algi-
nate, oxgall from Sigma-Aldrich (Germany), MRS broth and
MRS agar, sodium hydrogen phosphate, calcium chloride,
sodium hydroxide and hydrochloric acid from Merck (Ger-
many), and psyllium seed husk was supplied from Sidpur Sat
Isabgol (India).
2.2. Methods
2.2.1. Preparation of Inoculum. L. acidophilus was cultured
in MRS broth at 37◦C for 18 hours. Culture was harvested by
centrifugation at 700 RCF at 4◦Cf o r7m i na n dw a s h e dt wi c e
with saline and collected by centrifugation as above. The
washed bacterial cells were resuspended in 7mL saline, and
the cell count was determined using pour plate technique in
MRS agar in triplicate. The cell suspension divided in some
equal parts and consequently was used to prepare diﬀerent
formulations.
2.2.2. Extraction of Psyllium. Psyllium husk was extracted
by a method described by Guo et al. [8]w i t hs o m em o d -
iﬁcations. First, 5g psyllium husk was dispersed in 100mL
water at 80◦C over night under constant stirring at 50rpm,
after 18–20 hours the dispersion became a homogenous
gel. Consequently, the obtained gel was centrifuged (Hettich
Rotoﬁx 32 A, Germany) at 18000 RCF for 90min, to separate
the gel and the solution. The gel phase was dissolved in 2M
NaOH solution at room temperature for 2 hours; alkaline
solution was separated from the residue by centrifugation
(18000 RCF for 90min) and accordingly neutralized with
2M HCl. During the neutralization, a large amount of
gel-like yellow precipitate was produced and separated by
centrifugation (18000 RCF for 90min) from the soluble
fraction and washed three times with distilled water. The gel
precipitate was dried at 40◦C for 48 hours.
2.2.3. Preparation of Beads. The extrusion technique was
used to prepare ALG and ALG-PSL beads [15]. Sodium
alginate and psyllium solutions were sterilized at 121◦Cf o r
15min. The cooled ALG or ALG-PSL solutions (20mL) were
mixed with bacterial inoculum and gently stirred for 30min
to obtain a homogeneous suspension. The suspensions were
extruded dropwise through a 27 gage nozzle into sterile
hardening solution (CaCl2). The beads were shaken at
150rpm for 40min, isolated by aseptic ﬁltration (Whatman
No.1), washed twice with sterile water, and kept in 0.1%
w/v peptone solution at 4◦C. The prepared formulations are
shown in Table 1.
2.2.4. Size and Morphological Analysis. T h ep a r t i c l es i z e
of beads was assessed using optical microscopy (Dino-
lite, Taiwan) by Scion image analyzer software. Data were
collected from 60 beads in each sample, and mean particle
size was reported.
The topographical properties of prepared beads were
investigated by scanning electron microscopy (SEM)
(Philipse XL30, Holland) at an accelerating voltage of 20KV.
Prior to examination, samples were prepared on aluminum
stubs and coated with gold under argon atmosphere by
means of a sputter coater.
2.2.5.EncapsulationEﬃciency(EE). To determine the encap-
sulation eﬃciency, ﬁrstly prepared beads were mechanically
disintegrated in phosphate buﬀer (pH = 6.8), then the
number of entrapped cells after adequate dilution were
measured by pour plate method, and counts were expressed







where N is the number of viable entrapped cells released
from the beads and N0 is the number of free cells added to
the biopolymer mixture immediately before the production
procedure.
2.2.6. Viability of Encapsulated and Free L. acidophilus at
Low pH Condition. Low pH conditions were produced using
9g/L sodium chloride and 3.0g/L of pepsin and pH adjusted
to 1.8 with hydrochloric acid [16]. 100mg beads with
entrapped bacteria or 0.1mL of cell suspension were mixed
in 20mL of acid solution and incubated for 120min at 37◦CThe Scientiﬁc World Journal 3
with constant agitation at 50rpm. After incubation, beads
were disintegrated in phosphate buﬀer (pH = 6.8), then
1.0mL aliquot of the mixture removed and assayed using
pour plate method.
Thesurvival(%)ofthebacteriawascalculatedasfollows:
%S u r v i v a l
=

log CFU/g beads after 2 hours exposure to




2.2.7. Viability of Encapsulated and Free L. acidophilus at
High Bile Salt Concentration. Prepared beads after 2-hour
acidexposurewerewashedwithdistilledwater,removed,and
incubatedin50mLofhighbilecondition,containing6.8gof
monobasic potassium phosphate, and 10g/L of pancreatin
with pH adjusted to 6.8 ± 0.1 using sodium hydroxide and
0.5%w/voxgallfor2hoursat37◦Cwithconstantagitationat
50rpm [17]. Samples were then taken, and bacterial growth
was assayed using pour plate method.
2.2.8. Release of Encapsulated Cells and Free L. acidophilus in
Simulated Colonic pH Solution. The release of the prepared
beads was examined at simulated colonic pH solution as
described by Mandal et al. [18]. The beads were mixed with
50mL of simulated colonic pH solution containing 0.1M
monobasic potassium phosphate with pH adjusted to 7.4 ±
0.1 with sodium hydroxide and incubated for 20h at 37◦C
with constant agitation at 50rpm. Samples were taken at
diﬀerent time intervals, and bacterial growth was assayed
using pour plate method as described in Section 2.2.5.
2.2.9. Statistical Analyses. Statistical testing was carried out
using SPSS19. All of the experiments were performed in
triplicates. Data are presented as mean ± SD. The One-Way
ANOVA test was performed to assess the diﬀerence between
diﬀerent beads and control groups and P<0.05 considered
as a statistically signiﬁcant diﬀerence.
3. Results andDiscussion
3.1. Characterization of Prepared Beads: Size, Morphology,
Encapsulation Eﬃciency, and Surface Characteristic. In the
preliminary experiments, diﬀerent concentrations of ALG
(0.75 to 3% w/v) and CaCl2 as hardening solution (1 to
6%w/v) were examined. According to the results of this step,
it was found that uniform and spherical bead preparation by
ALG concentrations less than 1% (w/v) was quite diﬃcult
because of decreased viscosity and less ion sites for cross-
linkage [19]. Also, ALG concentrations more than 2% (w/v)
were too viscose to be extruded from the syringe. Hence,
the ALG concentrations between 1 to 2% w/v were selected.
Moreover,accordingtoourtests,4%w/vCaCl2 producedthe
best result and chosen as optimum hardening solution.
In the second step of preliminary tests, the concen-
trations of PSL to be incorporated in ALG beads were
optimized. Addition of PSL into ALG gel results in an
increase in the viscosity and adherence of resultant gel.
Table 1: Compositions of the studied formulation.













Indeed, incorporation of PSL in the concentrations more
than 0.3, 0.5, and 0.6%w/v to ALG in the concentrations of
2, 1.5, and 1%w/v, respectively, yields too adherent mixtures
to easily fabricate the beads. Consequently, the compositions
in Table 1 were selected as the formulations to be further
analyzed.
Table 2 shows results for diameters and encapsulation
eﬃciencies of diﬀerent ALG and ALG-PSL beads. As it can
be seen, beads ranging from 1.59 to 1.67mm for ALG
and from 1.61 to 1.80mm for ALG-PSL formulations were
achieved. The mean diameters of beads containing PSL were
signiﬁcantly higher than those without PSL (P<0.05)
that can be attributed to the viscosity of the resultant gel.
According to the studies in this regard, an increase in the
viscosity of the starter gel leads to the preparation of bigger
beads by the extrusion method [5]. Furthermore, narrow
range of size distribution was observed for all prepared
beads and no signiﬁcant diﬀerences in size (P>0.05)
were observed between beads contained or not L. acidophilus
loads.
Scanning electron microscopy images of our formula-
tionsalsoshowthattheresultantbeadsareinsphericalshape
(Figures 1(c) and 1(d)) with groups of entrapped bacteria
evident in the surfaces of the matrix (Figures 1(a) and 1(b)).
The beads prepared using ALG concentrations of 2%w/v
(F1) exhibited a smooth surface (Figure 1(a))a n dr e l a t i v e
small pores. On the other hand, optimum beads made using
1%w/v ALG have a rough surface and markedly open and
large pores (Figure 1(e)), that is in good agreement with
vast majority of other studies regarding the optimization
of alginate concentration for probiotic microencapsulation
[20]. On the other hand, as depicted in Figure 1(f), inclusion
of PSL into ALG obviously lowered the surface roughness
and pores of prepared beads and interestingly in the presence
ofPSL,evenlowerconcentrationsofALGcouldalsoproduce
smoother surface with reduced pores (Figure 1(f)).
The initial cell count of L. acidophilus before bead
preparation was 9.81 ± 0.02 logCFU/mL. High bacterial
cell entrapping in the range of 9.6 ± 0.06 to 9.78 ±
0.06(logCFU/g beads) was achieved in resultant beads
(Table 2). The results pertaining to EE indicated that there4 The Scientiﬁc World Journal
Table 2: Size, encapsulation eﬃciency, and % survival in acid condition of prepared formulations.
Formulation Diameter (mm) (n = 60) Count (CFU/g) after preparation Encapsulation eﬃciency (%) % Survival
F1 1.67 ±0.08 9.8 ±0.03 99.8 ±0.38 1 .1 ±1.1
F2 1.66 ±0.04 9.79 ±0.07 99.8 ±0.98 2 .3 ±0.2
F3 1.65 ±0.05 9.79 ±0.06 99.7 ±0.78 3 .2 ±0.7
F4 1.64 ±0.03 9.76 ±0.05 99.4 ±0.68 6 .6 ±0.3
F5 1.64 ±0.04 9.78 ±0.06 99.7 ±0.87 4 .5 ±2.5
F6 1.61 ±0.06 9.78 ±0.06 99.6 ±0.78 0 .9 ±1.1
F7 1.65 ±0.05 9.7 ±0.09 98.6 ±1.28 2 .1 ±0.4
F8 1.74 ±0.05 9.75 ±0.02 99.3 ±0.38 3 .4 ±1.6
F9 1.59 ±0.09 9.7 ±0.07 98.6 ±0.96 4 .4 ±1.5
F10 1.80 ±0.07 9.6 ±0.06 98.4 ±0.8 70.7 ± 0. 7
F11 1.71 ±0.04 9.61 ±0.07 98.4 ±0.87 4 .7 ±0.2
F12 1.77 ±0.09 9.65 ±0.04 98.0 ±0.5 76.0 ± 0. 3
Untreated cellsa —— — 3 9 .1 ±0.8
aInoculum count: 9.81 ±0.08CFU/mL.
(a) (b) (c)
(d) (e) (f)
Figure 1: SEM pictures of F1 (a, c); F4 (b, d); F9 (e); F12 (f) beads at a magniﬁcation of 2000x (a, b, e, f), of 97x (c) and of 83x (d).
was no considerable loss of viability for all prepared beads
and more than 98.9% cells for all beads were successfully
entrapped that can be due to the gentle method applied [4].
Furthermore, no signiﬁcant diﬀerences (P>0.05) regarding
the EE were observed between all formulations.
3.2. Viability of Free and Encapsulated Bacteria in Acid
Conditions. The protective eﬀects of diﬀerent coats of ALG
andALG-PSLafter2-hourexposuretoacidconditions(pH=
1.8) are compared to untreated cells, and results are



































Figure 2: The viability of L. acidophilus (CFU/g) encapsulated in
diﬀerent ALG or ALG-PSL beads (F1–F12) and untreated cells. (a)
Counts of the bacteria after 2h acid exposure, (b) Initial counts of
prepared beads and untreated cell count.
As it can be seen from bar graphs in Figure 2, the
initial inoculum count of untreated L. acidophilus
was 9.81 ±0.08logCFU/g which declined to 5.06 ±
0.06logCFU/g after acid exposure for 2 hours (around
39% survival). On the other hand, in our prepared beads
with the initial cell numbers ranged between 9.6 ± 0.06 to
9.8 ± 0.03logCFU/g, after 2h acid exposure, the counts
were 7.03 ± 0.1t o8 .43 ± 0.04logCFU/g indicating more
than 70% survival in all formulations. Overall, it is clear that
survived bacteria after acid exposure, in all prepared beads
were signiﬁcantly (P<0.05) higher than those of untreated
cells. In fact, around 5log reduction in bacterial count in
the case of untreated L. acidophilus decreased to 1–3log
reduction among our obtained beads after 2h acid exposure,
and it can be concluded that coating of the bacteria as ALG
or ALG-PSL beads can improve the viability of L. acidophilus
in that conditions. There are numerous studies in this
regard to protect probiotics by encapsulation in alginates
beads using diﬀerent techniques [21]. However, obtained
results are controversial. In some cases, the investigations
support our ﬁnding about the ability of ALG coat in
protection of bacteria in acid conditions [15, 19, 22, 23].
For instance, Sohail et al. reported that encapsulation of
probiotic bacteria in cross-linked alginate beads is of major
interest for improving the survivability in harsh acid and bile
environment [2]. Furthermore, Mokarram and collogues
showed the eﬃciency of multistage alginate coating on
survivability of probiotic bacteria in simulated gastric and
intestinal juices [4]. However, Sultana and coworkers found
that encapsulation of bacteria in alginate beads did not
eﬀectively protect the organisms from high acidity [24].
On the other hand, incorporation of PSL into alginate
beads resulted in a rise in the viability of L. acidophilus in
thosebeadsinacidconditionsandthiseﬀectismoreobvious
in higher concentrations of PSL. For instance, incorporation
of 0.1 and 0.6%w/v PSL into 2%w/v (F2) and 1%w/v
(F12) ALG solutions increased the survival around 1% and







































Figure 3: The viability of L. acidophilus (CFU/g) encapsulated in
diﬀerent ALG or ALG-PSL formulations (F1–F12) and untreated
cells. (a) The counts after 2h acid exposure, (b) The counts after 2h
acid exposure followed by 2h bile exposure.
addition of PSL is in line with our expectations, and it can be
attributed to the total concentration of polymers blend used,
as the survival of L. acidophilus in the beads with the same
total amount of polymers showed no signiﬁcant diﬀerences
(P>0.05) (F1 and F8 or F5 and F11). Moreover, the rising
trend in the viability values by increase in the proportion
of PSL can be attributed to the alginate concentration.
As in the lower concentrations of alginate (1%w/v), the
PSL eﬀect is more dominant probably due to the fact
that ALG concentration is insuﬃcient for protection and
addition of PSL increases the total polymer concentration
and brings it to the appropriate point to remarkably increase
the protection of the cells against acid conditions. Polymer
blending is a simple yet attractive method to provide
combined properties of polymers to a system and overcome
their limitations [25]. This kind of compositions is widely
used in encapsulation of probiotics. For instance, Albertini
and coworkers, in good agreement with our results, reported
that the incorporation of XG or CAP within the 3%w/v
of alginate solution increased the survival of the probiotic
bacteria in acid conditions [3]. Moreover, encapsulation of
probioticinalginate-starchblend[26]alsoshowedimproved
level of protection against acidic condition.
3.3. Viability of Encapsulated and Free L. acidophilus at
High Bile Salt Concentration. The eﬀect of 2h exposure to
0.5%w/v oxgall on the survival of L. acidophilus (passed
through acidic conditions) in prepared beads and untreated
cells is demonstrated in Figure 3.
It is clear that L. acidophilus encapsulated in either
ALG or ALG-PSL beads showed better survivability (less
than 2.5log reduction) after 2h bile exposure compared to
those of untreated (P<0.05) that is dropped by around
4.5logCFU/mL after 2h bile exposure. According to the
previous studies, survivability of encapsulated probiotics
against harsh environmental conditions especially bile toler-


































































































Figure 4: Release of L. acidophilus (CFU/g) in simulated colon pH solution (a) formulations F1–F4 and untreated cells (UT); (b)
formulations F5–F8 and UT; (c) formulations F9–F12 and UT.
concurs with the studies of Sohail et al., who reported that
encapsulation of L. acidophilus in extruded macrobeads was
eﬀective in maintaining cell viability [2].
However, between the prepared beads, addition of less
than 0.4%w/v PSL into ALG did not show signiﬁcant
changes in the viability of the bacteria in the presence of
0.5%w/v oxgall (P<0.05) and the positive eﬀect of PSL on
the survivability of the bacteria is more evident in the lower
concentrationsofALG.Asasamemannerwithacidexposure
results, we can discuss here that the rise in the total amount
of polymer can be probably the reason of this phenomena.
For instance, incorporation of 0.6%w/v PSL into 1%w/v




3.4. Release of Encapsulated and Free Bacteria in Simulated
Colonic pH Solution. The bacterial release proﬁle from the
prepared beads in simulated colonic pH solution at diﬀerent
time intervals is illustrated in Figure 4. The release of
probiotic bacteria from the beads and their colonization
and growth in colon is crucial to take the advantages of
the beneﬁcial cells. Indeed if the prepared system does notThe Scientiﬁc World Journal 7
disintegrate and release its payloads in adequate time, it
leaves the body without producing any claimed beneﬁts [18].
According to our results, during the ﬁrst 3h incubation in
simulated colon pH solution, the cells increasingly released
from all of the prepared beads to reach the level ranged
6-7CFU/g, where the situation started to be remarkably
diﬀerent for coats of ALG-PSL in comparison with those of
ALG.
Among beads prepared with ALG (F1, F5, and F9), in
3h, the counts hit their maximum level and beyond that no
signiﬁcantchangeswereobservedincellnumbers(P>0.05).
It can be concluded that the ALG concentrations had no
considerable eﬀect on the release of L. acidophilus from
the prepared beads. This ﬁnding also is in good agreement
with Mandal et al. [18]. They reported that the count of
L. casei in simulated colonic pH solution rose to its highest
point in 60min and after that remained constant. Moreover,
accordingtoPicotandLacroix,aprogressivereleaseofcoated
cells in whey protein in simulated intestinal conditions
occurred [27].
In sharp contrast, in the case of beads prepared using
ALG-PSL, not only the bacteria completely released from
the beads but also diﬀerent rates of bacterial growth after
3h was observed indicating a stimulating eﬀect of PSL on
the bacteria. Our data revealed that higher concentrations
of PSL produced the greater stimulation eﬀect on bacteria,
as 0.6%w/v PSL in F12 showed more than 4log rise in
bacterial count. However, in F2 with minimum amount of
PSL (0.1%w/v), lowest amount of growth was observed
(under 2log). The stimulation eﬀect of PSL on L. acidophilus
can be probably attributed to its structure as a soluble ﬁber.
Based on prebiotic deﬁnition, nondigestible food ingredients
such as carbohydrates in the form of soluble ﬁber can
stimulate the growth and/or activity of bacteria. Indeed,
in some cases, PSL has been used as prebiotic in diﬀerent
situations [10–13]. For instance, in a randomized controlled
trial for treatment of patients with ulcerative colitis using
synbiotic versus probiotic or prebiotic, PSL has been used
as prebiotic and the results have shown that the quality of
life in patients has been improved [10]. However, PSL has
not been oﬃcially designated as a prebiotic so far and in vivo
studiesinthisregardsareinprogress.Inastudy,theprebiotic
potential of PSL ﬁber in healthy women on biﬁdobacteria
was evaluated by Elli and colleagues [28], and they reported
that PSL seed husk can be metabolized by biﬁdobacteria only
after partial hydrolysis.
In summary, whatever the prebiotic activity oﬃcially
accepted or not for PSL, it is important to note that based
on our data, it is assumable that PSL can potentially act as
a prebiotic and preparation of PSL-ALG beads containing L.
acidophilus improved its delivery to the active site.
4. Conclusion
ALG-PSL beads encapsulating probiotic L. acidophilus in
the size range of 1.61 ± 0.06 to 1.80 ± 0.07mm with EE
higher than 98% were prepared using extrusion method.
Inclusion of PSL into ALG beads maintained the survival
rate of L. acidophilus in acid and bile conditions as well as
considerable stimulation eﬀect on the bacteria in simulated
colon pH solution. Psyllium as a pharmacologically active
ingredient for gastrointestinal disease and a potential pre-
biotic can be a suitable candidate to partially replace with
alginate for encapsulation of probiotic bacteria.
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